Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | -3.49% | -.--% | +3.75% |
May. 16 | Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing | MT |
May. 13 | Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise | MT |
Business Summary
Number of employees: 8
Managers
Managers | Title | Age | Since |
---|---|---|---|
Niall O'Donnell
FOU | Founder | 51 | - |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 20-12-08 |
Michael Grey
FOU | Founder | 71 | 14-09-21 |
Jennifer P. Lam
ADM | Chief Administrative Officer | - | 21-07-31 |
Michael Cruse
COO | Chief Operating Officer | 52 | 20-11-30 |
Chief Tech/Sci/R&D Officer | 64 | 17-12-31 | |
Ashley Hall
PRN | Corporate Officer/Principal | 52 | 21-10-10 |
Corporate Officer/Principal | - | 17-12-31 | |
Wendy Johnson
PRN | Corporate Officer/Principal | 72 | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Grey
FOU | Founder | 71 | 14-09-21 |
Director/Board Member | 64 | 17-11-30 | |
Paul Hoelscher
BRD | Director/Board Member | 59 | 22-01-19 |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 20-12-08 |
Stacey Seltzer
BRD | Director/Board Member | 47 | 20-11-30 |
Niall O'Donnell
FOU | Founder | 51 | - |
Bali Muralidhar
BRD | Director/Board Member | 44 | 21-03-31 |
Roshawn Blunt
BRD | Director/Board Member | 49 | 21-12-31 |
Eric Dube
BRD | Director/Board Member | 51 | 21-03-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,420,808 | 31,701,938 ( 94.86 %) | 0 | 94.86 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.75% | 55.48M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- RPHM Stock
- Company Reneo Pharmaceuticals, Inc.